Propel(x) Blog | Deep Technology Focus

About Us
Portfolio
How it works
- Invest
- Fundraise
- Advise
Insights
- Podcast
- Events
- Blog
Sign In
Join

Browse articles by categories

Angel Investing Tips

Deep Technology

Startup Tips

User Tips

Industry Trends

Aerospace / Transportation

Energy / Green Technologies

Food & Agriculture

IT & Communications

Life Sciences

Deal Profile

Search for:

Diligence on Deep Technology Startups

Conducting Diligence on Deep Technology Startups

Swati Chaturvedi April 24th, 2018

Angel Investing Tips Deep Technology Uncategorized

How will Artificial Intelligence Affect Your Industry?

How Artificial Intelligence Will Impact Your Industry? Ask the Expert

Luke Renner April 16th, 2018

The Rise of Carbon Fiber

The Rise of Carbon Fiber: Why a Space-Age Material May Finally Come to Earth.

Luke Renner April 5th, 2018

Deep Technology Energy / Green Technologies Industry Trends

Angel investing tips

Angel Investing Tips: 35 Investors Share their Tips on Angel Investing.

Luke Renner April 4th, 2018

Angel Investing Tips Investor Roundup

Cellular Proximity

Cellular Proximity: Why an Unsolicited Review to Science Magazine may hold the key to the next wave of treatments.

Luke Renner March 28th, 2018

Biology Healthcare Life Sciences

Venture Financing - Smart phone and headphones

1Mby1M podcasts discuss the ins and outs of early stage venture financing

Reuben Bailon March 22nd, 2018

Angel Investing Tips Fundraising 101

why emergent bias should terrify you

Why Emergent Bias in Machine Learning Should Terrify You

Haley Sheetz March 15th, 2018

Deep Technology

MIT new - Deep Tech innovations

Ask the Experts: What’s the Biggest Deep Tech Innovation You Expect to See From Universities This Year?

Luke Renner March 14th, 2018

Deep Technology Expert Roundup

A doctor uses telemedecine to remotely treat his patient. Source: Athenahealth

Deep Tech Innovations in Diagnostics and Medical Technology Are Starting to Transform Healthcare

Luke Renner March 8th, 2018

Deep Technology Industry Trends IT & Communications Life Sciences

1
2
3
4
...
10

Popular posts

Guest Post: Cancer Immunotherapy – Defense Against Enemies Foreign and Domestic

Deep Technology
Deep Tech Innovations in Diagnostics and Medical Technology Are Starting to Transform Healthcare

Deep Technology Industry Trends IT & Communications Life Sciences
How To Become an Angel Investor

Angel Investing Tips Angel Keyterms User Tips

ABOUT US
How it works
- Invest
- Fundraise
- Advise
- FAQs
JOIN
Learn
- Podcast
- Events
- Blog
LEGAL

© 2020 PROPEL(X) - All Rights Reserved.

This site is operated by Propel(x) Inc. (“Propel(x)”), which is not a registered broker dealer. Propel(x) does not give investment advice, endorsement, analysis or recommendations with respect to any securities. All securities posted here are being offered by, and all information included on this site is the responsibility of, the applicable issuer of such securities. Propel(x) has not taken steps to verify the adequacy, accuracy, or completeness of the information. Neither Propel(x) nor any of its officers, directors, agents and employees makes any warranty, express or implied, of any kind related to the adequacy, accuracy or completeness of any information on this site or the use of information on this site. By accessing this site and any pages thereof, you agree to be bound by the Terms of Use and Privacy Policy.

Certain offerings posted on the platform and so designated are offered by Hubble Investments, Member FINRA / SIPC and an affiliate of Propel(x), located at EvoNexus Silicon Valley FinTech Incubator, 950 Park Place, Building 950/1, San Mateo CA 94403. Hubble Investments does not make investment recommendations and no communication, through this website or in any other medium should be construed as a recommendation for any security offered on or off this investment platform. This website is intended solely for qualified investors. Private investments are highly illiquid and risky and are not suitable for all investors. Investments in early-stage private companies should only be part of your overall investment portfolio. Furthermore, the allocation to this asset sub-class may be best fulfilled through a balanced portfolio of different start-ups. Investments in startups are highly illiquid and those investors who cannot hold an investment for the long term (at least 5-7 years) should not invest.

Questions? Feedback? Olark live chat software